US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Cipher Pharms Inc Ord (TSX:CPH)

13.65 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cipher Pharms Inc Ord

News headline image
Cipher Pharmaceuticals Q2 Earnings Call Highlights ↗
Cipher Pharmaceuticals (TSE:CPH) reported lower second-quarter revenue and earnings as sales of its U.S. Natroba treatment declined, while its Canadian Epuris product posted growth and market-share... 
Via MarketBeat
Topics Earnings
News headline image
Cipher Pharmaceuticals to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
Via ACCESSWIRE
News headline image
OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX
From OTC Markets
Via GlobeNewswire
News headline image
Optimi Health Signs Two New Supply Agreements In Less Than a Week ↗
Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies. 
Via Benzinga